Skip to Content

Weekly Drug News Round Up - January 21, 2015

Novartis Wins 1st Approval in Race for New Psoriasis Blockbusters

Common side effects with Cosentyx include diarrhea and upper respiratory infections Read More...

Today, the U.S. Food and Drug Administration approved Cosentyx (secukinumab), a subcutaneous injection to treat adults with moderate-to-severe plaque psoriasis. The most common form of psoriasis is plaque psoriasis, in which patients develop thick, reddened skin with white patches called scales. Cosentyx is a selective interleukin-17A inhibitor that blocks the inflammatory response in the development of plaque psoriasis. In Phase III clinical trials, Cosentyx compared to placebo achieved greater clinical response with skin that was clear or almost clear, and was rated superior to Enbrel and Stelara. In addition, a host of psoriasis competition, from AstraZeneca's brodalumab to Johnson & Johnson's guselkumab, crowds the pipeline.

Baxter’s Phoxillum Wins Approval

Baxter anticipates Phoxillum phosphate-containing solutions will be available in Q2 2015 Read More...

The U.S. Food and Drug Administration (FDA) has approved Phoxillum Renal Replacement Solutions (BK4/2.5 and B22K4/0). Phoxillum solution is used as a plasma volume replacement solution in Continuous Renal Replacement Therapy (CRRT) to correct electrolyte and acid-base imbalances. It may also be used in case of drug poisoning when CRRT is used to remove dialyzable substances. Hypophosphatemia (abnormally low concentration of phosphate in the blood) is a common electrolyte disturbance in patients treated with CRRT. Phoxillum is the only FDA approved pre-mixed solution containing phosphate in a 5L bag.

Flu Vaccine Less Than Perfect This Year

The new H3N2 virus did not appear until after flu strains were chosen for the current vaccine Read More…

Never fear, if you got your flu vaccine this year you still did the right thing. Authorities are reporting the 2014-2015 influenza vaccine is way less than perfect. A new study in Morbidity and Mortality Weekly Report finds the vaccine reduces your risk of needing medical care because of flu by only 23 percent. Even if you did not receive the flu shot, you should still get it, as it can lessen symptoms if you should land on your back with the flu virus. Early treatment with antiviral drugs such as Tamiflu or Relenza and preventing the spread of flu by washing hands and covering coughs is especially important this year.

What Are the Recommended Treatments for Migraine?

Researchers reviewed recent scientific literature and concluded that a number of classes of drugs were effective Read More...

In a recent study published in the journal Headache, researchers reported on the best regular treatments for migraines, which include the triptans, dihydroergotamine (DHE) and many NSAIDS (nonsteroidal anti-inflammatory drugs that include aspirin, ibuprofen and naproxen). Powerful opioid pain drugs such as butorphanol, codeine/acetaminophen and tramadol/acetaminophen are likely effective but are not recommended for regular use. Migraines affect about 36 million Americans, according to the American Migraine Foundation. The study will form the basis of new American Headache Society guidelines for the treatment of migraine.

FDA: Relief From Overactive Bladder Symptoms

Patient with OAB should seek the advice of a healthcare professional to define symptoms and determine the best course of treatment Read More...

Overactive bladder (OAB) symptoms affect more than 33 million Americans. But the good news is that there are many therapies for these symptoms. They include oral medications, a patch or gel applied to the skin, the first over-the-counter (OTC) treatment for women with overactive bladder, and bladder injections for patients with more severe symptoms. Recently, FDA approved Myrbetriq (mirabegron), an oral medication that improves the bladder’s ability to store urine by relaxing the bladder muscle during filling. Other options for overactive bladder include the OTC patch Oxytrol for Women, and even the Botox injection. Review more information about OAB in this slideshow.